Comparative properties of five human ovarian adenocarcinoma cell lines.
about
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancerrIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibitionTissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer PhenotypesInsulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancerPrioritizing therapeutic targets using patient-derived xenograft modelsReduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomasRegulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancerOvarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesNutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasKallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft modelDifferential platelet levels affect response to taxane-based therapy in ovarian cancer.Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.Characterization of three new serous epithelial ovarian cancer cell lines.Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burdenModeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach.Stem cell pathways contribute to clinical chemoresistance in ovarian cancerFlutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristicsLoss of BRCA1-A complex function in RAP80 null tumor cellsTargeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Dopamine blocks stress-mediated ovarian carcinoma growth.Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.Functional and evolutionary significance of human microRNA seed region mutations.Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cellsProduction of a monoclonal antibody specific for seminomas and dysgerminomas.Identification of epithelial ovarian tumor-specific aptamers.Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas.
P2860
Q24650026-B8D8BCA5-86E5-4CB2-BDB3-F93D45B20C7BQ24805224-12F4D9EF-9BFA-449C-B792-66FA0BF8CFFEQ26781924-F64F75B6-D567-48D9-9917-4EE725867B84Q27322873-3A231A3D-DBA5-49DC-A79E-3969C480081AQ28083993-7042AC58-443C-4A4B-BC27-F0AF8891305AQ28365024-CAF543A0-9590-4CE3-A7D4-4721CCBF9F2CQ28534173-557DC33F-4A24-483F-B384-93CE726129F6Q28538059-C3CD3B62-0B8B-4D2C-BCE4-258FB1A7AC3FQ28543021-EEEFB11B-17F4-476B-A9DF-D2CE34C760ADQ28547093-50957B55-661A-4A99-9A4D-9EB05BAA2533Q28742738-C43C8B96-AEFF-411C-A334-E93F8C5D8BD5Q30361046-65259F14-300A-4492-9A61-4FD2E40EAADBQ33308740-8F47F94F-008D-4011-B912-104D2048B265Q33338286-D14E9211-1770-46BD-93E9-130936F1C81CQ33403766-9921242E-A7C9-4A6A-97C2-E6DAB7591C05Q33533746-C3E0DB1A-DEB7-48AF-9446-281643628B55Q33588267-3368357B-6AF9-452E-9B64-EA50A509AA8EQ33628532-3DB61256-1844-4CA7-9A80-0DB607CEDCD0Q33641924-DD9271F4-1C6E-4E4C-838D-566A67E94FD7Q33930051-0687CD75-67FC-4254-A494-FE5ECA07960BQ33980036-642F8A9C-7FEB-4062-A191-0808F0D462EAQ34092005-6E8A99A3-4DC7-4D2E-B8F7-DF9C59D8BDFFQ34135327-8FFABFEC-9FC6-4FE8-BEAA-08E131E73F1BQ34260479-4FF8A737-98D7-4405-BA9A-344AE2474D64Q34334489-65FE98FA-992B-4D77-BB5B-3D8AF9313805Q34336205-C58BC643-1852-47D9-962F-00867E780C81Q34420393-84CC2132-3BD7-4D44-961C-388EE2E673C6Q34624192-67FAF5CD-E613-4D56-9A45-85E22656183BQ34738849-E34F3B4F-829F-4AE5-9DF8-BB8628D94A86Q35023940-DD9184DC-095F-4B89-825E-2F366C1209F8Q35196364-00535E65-F6A2-47DC-AC11-21F01BA5E269Q35209365-4933C91C-FF93-4EED-9165-9BFCA52E7D49Q35514457-D788AA8D-F2F6-4C5B-80E8-7627653BE352Q35538822-A545F1F5-533C-46A4-A79E-6EBDE1D3A3EFQ35617702-22AC8946-ABA4-4641-9F7A-1B811DF35653Q35635298-553CB75F-B7D1-4141-BB47-739A0C04DB41Q35650181-B3F85D85-DDF7-4DFE-97F9-7541025348EAQ35763273-CE3753F8-858B-4180-8109-2DE75D96C409Q35793808-6F56C775-BAF4-480D-90F6-4CDF8917BCF1Q35811506-9F5F64ED-0CE1-4141-9BAB-36CF1E7A79D6
P2860
Comparative properties of five human ovarian adenocarcinoma cell lines.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Comparative properties of five human ovarian adenocarcinoma cell lines.
@en
Comparative properties of five human ovarian adenocarcinoma cell lines.
@nl
type
label
Comparative properties of five human ovarian adenocarcinoma cell lines.
@en
Comparative properties of five human ovarian adenocarcinoma cell lines.
@nl
prefLabel
Comparative properties of five human ovarian adenocarcinoma cell lines.
@en
Comparative properties of five human ovarian adenocarcinoma cell lines.
@nl
P2093
P4510
P1433
P1476
Comparative properties of five human ovarian adenocarcinoma cell lines.
@en
P2093
P304
P407
P577
1985-08-01T00:00:00Z